Colonoscopy is the gold standard for detecting colon cancer, but every year about 50 million people in the U.S. who qualify for a colonoscopy don't get it done, according to the American Cancer ...
Guardant Health aims to reshape how the U.S. gets screened for colorectal cancer, by claiming a groundbreaking FDA approval for a tumor-detecting blood test aimed at a population of about 120 million ...
A new European study on colonoscopies – the largest of its kind – has complicated results, and it’s left some people wondering whether they should have the procedure to screen for colon cancer. “I ...
A study by Pickhardt et al. in the most recent issue of the Annals of Internal Medicine reports a miss rate of approximately 10 percent for large (>5mm) precancerous polyps during conventional ...
Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...
A colonoscopy is recommended every decade for people over 45. The screening is used to detect colon cancer. But roughly 40% of eligible Americans don't get a colonoscopy, often because they don't want ...
Money Talks News on MSN
This at-home test detects cancer as effectively as a colonoscopy
FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...
On Sunday, the New England Journal of Medicine published the interim results of a landmark trial examining the effect of inviting people to colonoscopy screening. The paper, which STAT covered, ...
A Knoxville company has launched a blood test locally that could reshape how patients get one of the more unpleasant but essential medical tests: screening for colorectal cancer. The test, called ...
Researchers investigated whether the time interval between a positive FIT result and follow-up colonoscopy is linked to risk for CRC.
Please provide your email address to receive an email when new articles are posted on . The researchers conducted a mixed-methods cohort study to assess FU-CY rates after a positive SBT result and to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈